1 year return (CAGR)
-76.38%
Atrium Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
RNA
9.50
-0.59 (-5.85%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
13.08%
5 year return (CAGR)
-16.23%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
162.50M
Price/Sales
4.52
Ent value
155.79M
Price/Book
0.76
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
19.41%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 10.11 |
| Daily high | 10.11 |
| Daily low | 9.50 |
| Daily Volume | 356K |
| All-time high | 72.93 |
| 1y analyst estimate | 25.00 |
| Beta | 0.93 |
| EPS (TTM) | -15.16 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| RNA | S&P500 | |
| Current price drop from All-time high | -86.97% | -3.06% |
| Highest price drop | -86.97% | -56.47% |
| Date of highest drop | 16 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -41.63% | -10.68% |
| Avg time to new high | 32 days | 12 days |
| Max time to new high | 942 days | 1805 days |
News
